[1] |
LIU X, LIU XP, GAO XS, et al. Progress on dyslipidemia in primary biliary cholangitis[J/CD]. Chin J Liver Dis (Electronic Version), 2020, 12(3): 17-22. DOI: 10.3969/j.issn.1674-7380.2020.03.004.
刘晓, 刘亚平, 高学松, 等. 原发性胆汁性胆管炎合并血脂异常研究进展[J/CD]. 中国肝脏病杂志(电子版), 2020, 12(3): 17-22. DOI: 10.3969/j.issn.1674-7380.2020.03.004.
|
[2] |
YANG YF, DENG ZH. Immune mechanism of biliary epithelial cell injury in the small intrahepatic bile ducts in primary biliary cholangitis[J]. J Clin Hepatol, 2021, 37(6): 1466-1468. DOI: 10.3969/j.issn.1001-5256.2021.06.051.
杨雅斐, 邓志华. 原发性胆汁性胆管炎肝内小胆管上皮细胞损伤的免疫学机制[J]. 临床肝胆病杂志, 2021, 37(6): 1466-1468. DOI: 10.3969/j.issn.1001-5256.2021.06.051.
|
[3] |
EFE C, TORGUTALP M, HENRIKSSON I, et al. Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome[J]. J Gastroenterol Hepatol, 2021, 36(4): 936-942. DOI: 10.1111/jgh.15214.
|
[4] |
TU RF, YANG X, TANG YM. Research advances in primary biliary cholangitis with extrahepatic autoimmune diseases[J]. J Clin Hepatol, 2020, 36(6): 1398-1401. DOI: 10.3969/j.issn.1001-5256.2020.06.046.
涂荣芳, 杨雪, 唐映梅. 原发性胆汁性胆管炎合并肝外自身免疫性疾病的研究进展[J]. 临床肝胆病杂志, 2020, 36(6): 1398-1401. DOI: 10.3969/j.issn.1001-5256.2020.06.046.
|
[5] |
RENOUX M, BEAUGRAND M, LÉVY VG, et al. Primary biliary cirrhosis and pernicious anemia. A fortuitous association? (author's transl)[J]. Gastroenterol Clin Biol, 1980, 4(2): 109-113.
|
[6] |
JAZIA EB, KHALIFA M, ABDELKADER AB, et al. A case of primary biliary cirrhosis associated with pernicious anemia: A case report[J]. Cases J, 2010, 3: 11. DOI: 10.1186/1757-1626-3-11.
|
[7] |
ZHANG FC, WANG L, SHUAI ZW, et al. Recommendations for diagnosis and treatment of primary biliary cholangitis in China (2021)[J]. Chin J Intern Med, 2021, 60(8): 709-715. DOI: 10.3760/cma.j.cn112138-20210520-00360.
张奉春, 王立, 帅宗文, 等. 原发性胆汁性胆管炎诊疗规范(2021)[J]. 中华内科杂志, 2021, 60(8): 709-715. DOI: 10.3760/cma.j.cn112138-20210520-00360.
|
[8] |
LIU M, HUANG ZP. The clinical significance of the differential expression of lactate dehydrogenase and other indicators in megaloblastic anemia[J]. J Clin Intern Med, 2021, 38(4): 271-272. DOI: 10.3969/j.issn.1001-9057.2021.04.018.
刘敏, 黄知平. 乳酸脱氢酶及其他多项指标在巨幼细胞性贫血中表达差异的临床意义[J]. 临床内科杂志, 2021, 38(4): 271-272. DOI: 10.3969/j.issn.1001-9057.2021.04.018.
|
[9] |
SOCHA DS, DESOUZA SI, FLAGG A, et al. Severe megaloblastic anemia: Vitamin deficiency and other causes[J]. Cleve Clin J Med, 2020, 87(3): 153-164. DOI: 10.3949/ccjm.87a.19072.
|
[10] |
CHUNG CS, HSU YC, HUANG SY, et al. Primary biliary cirrhosis associated with pernicious anemia[J]. Can Fam Physician, 2010, 56(9): 889-891.
|
[11] |
EPSTEIN O, THOMAS HC, SHERLOCK S. Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease[J]. Lancet, 1980, 1(8179): 1166-1168. DOI: 10.1016/s0140-6736(80)91621-9.
|
[12] |
LIASKOS C, NORMAN GL, MOULAS A, et al. Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis[J]. Clin Chim Acta, 2010, 411(5-6): 411-415. DOI: 10.1016/j.cca.2009.12.012.
|
[13] |
DOHMEN K. Primary biliary cirrhosis and pernicious anemia[J]. J Gastroenterol Hepatol, 2001, 16(12): 1316-1318. DOI: 10.1046/j.1440-1746.2001.02614.x.
|
[14] |
ZHANG YG, WANG S, ZUO LJ, et al. Relationship between Helicobacter pylori infection and liver diseases[J]. Chin J Gerontol, 2021, 41(22): 5143-5145. DOI: 10.3969/j.issn.1005-9202.2021.22.077.
张永贵, 王帅, 左丽娟, 等. 幽门螺杆菌感染与肝脏疾病的关系[J]. 中国老年学杂志, 2021, 41(22): 5143-5145. DOI: 10.3969/j.issn.1005-9202.2021.22.077.
|